Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 

Show More News:
 Watch more news

News search related to the stock Bristol-Myers Squ (ordered by date):

  1. What's Happening With Bristol Myers Squibb Stock?  Forbes
  2. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know  yahoo.com
  3. Bristol Myers Squibb Shares Are Still Undervalued (NYSE:BMY)  Seeking Alpha
  4. What Does This Regulatory News Mean for Bristol Myers Squibb's Shareholders?  Motley Fool
  5. Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference  Business Wire
Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know  Yahoo Finance Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?  Trefis Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)  Seeking Alpha Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year  Nasdaq Inside Century Therapeutics' potential $3B deal with Bristol Myers Squibb - Philadelphia Business Journal  Philadelphia Business Journal Do These 3 Checks Before Buying Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend  Nasdaq Bristol-Myers Squibb (NYSE:BMY) Has Announced That It Will Be Increasing Its Dividend To US$0.54  Simply Wall St Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers  FiercePharma Bristol Myers Squibb exec on the company?s growth in Seattle and beating cancer with immune cells  GeekWire BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to Study Mecbotamab Vedotin (BA3011) and Ozuriftamab Vedotin (BA3021) in Combination with OpdivoŽ (nivolumab) for Treatment of Solid Tumors  Yahoo Finance Hikari Power Ltd Buys Alphabet Inc, Vanguard Health Care ETF, Bristol-Myers Squibb Co, Sells ...  Yahoo Finance The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin  Yahoo Finance 4 Biotech Acquisitions We'd Like to See in 2022  Motley Fool Bristol Myers Squibb - BMY - Stock Price & News  Motley Fool Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials  Forbes Here?s Why Bristol Myers Squibb Stock Is Undervalued At $63  Forbes IVE, PM, MDT, BMY: Large Inflows Detected at ETF  Nasdaq Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. (Eastern Time)  Business Wire Bristol-Myers Squibb: Underperformance Is Temporary  Seeking Alpha Here's Why Bristol Myers Squibb Stock Is Heating Up Today  The Motley Fool Bristol Myers Squibb Announces Dividend  Business Wire Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline  Bloomberg 3 Big FDA Approvals to Watch For in Q1 2022  The Motley Fool 3 Top Stock Trades for the Week of Jan. 10, 2022  Nasdaq Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?  Motley Fool U.S. FTC okays changes to Bristol Meyers Squibb divestiture agreement  Reuters January Buffett Dividend Dogs Show 3 Dandy Dynamutts  Seeking Alpha Bristol-Myers Squibb (BMY) Q1 2021 Earnings Call Transcript  Motley Fool Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week  Motley Fool Fitch Affirms Bristol-Myers Squibb's IDR at 'A-'; Withdraws Ratings; Outlook Revised to Stable  Fitch Ratings Bristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX  MarketWatch Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock  Forbes Nektar And Bristol Myers Squibb Expecting Bempeg Approval  Seeking Alpha Sanofi partners with AI firm Exscientia to develop up to 15 new drugs  Reuters Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential  Seeking Alpha Bristol Myers Squibb Awards ?Golden Tickets? to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs  Business Wire Bristol Myers to pay up to $1.56 bln to develop, sell Agenus's cancer therapy (May 18)  Reuters Bristol Myers Squibb Has Unique Cash Flow Strength  Seeking Alpha Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at Morgan Stanley 19th Annual Global Healthcare Brokers Conference (Transcript)  Seeking Alpha Bristol Myers Squibb's Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency  Business Wire 3 Reasons To Invest Like Buffett And Buy Bristol Myers  Seeking Alpha Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022  Yahoo Finance Here is What Hedge Funds Think About Bristol Myers Squibb Company (BMY)  Yahoo Finance Bristol-Myers Is Said to Have Weighed Offer for Acceleron  Bloomberg Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly  Forbes 3 Strong Stocks To Buy In A Weak Market  Investing.com Bristol-Myers Squibb (BMY) Q4 2020 Earnings Call Transcript  Motley Fool Bristol's Ulcerative Colitis Trial Disappoints. The Stock Is Falling.  Barron's We Wouldn't Be Too Quick To Buy Bristol-Myers Squibb Company (NYSE:BMY) Before It Goes Ex-Dividend  Nasdaq Bristol Myers Squibb to Present Data Across Robust Cardiovascular Portfolio at American Heart Association Scientific Sessions 2021  Yahoo Finance Bristol Myers (BMY) sBLA for Reblozyl Gets Priority Review  Nasdaq Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy?  The Motley Fool Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate  Reuters BRISTOL MYERS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company -  Business Wire Is Bristol Myers Squibb (BMY) Stock A Buy or Sell?  Yahoo Finance CLAIMSFILER ALERTS BRISTOL MYERS Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY  PRNewswire Bristol Myers Squibb?s Breyanzi (lisocabtagene maraleucel) Significantly Improves Outcomes, Showing Superiority Over 20-Year Standard of Care in Second-Line Relapsed or Refractory Large B-cell Lymphoma Based on TRANSFORM Study Results  Yahoo Finance BRISTOL-MYERS CVR INVESTORS: December 6, 2021 Filing Deadline in Class Action ? Contact Lieff Cabraser  Business Wire Bristol Myers Squibb Reports First Quarter Financial Results for 2021  Business Wire BRISTOL MYERS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Bristol-Myers Squibb Company - BMY  Yahoo Finance Bristol Myers Squibb: A Classic Buffett Style 'Fat Pitch'  Seeking Alpha Bristol Myers Squibb Provides Update on Status of Contingent Value Rights  Business Wire Bristol Myers Gets Europe OK for Zeposia in Ulcerative Colitis >BMY  MarketWatch Bristol-Myers to require U.S., Puerto Rico staff to be vaccinated  Reuters Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for September 30, 2021  Nasdaq Why Bristol Myers Stock Offers More Than Just A 3.44% Dividend Yield  Seeking Alpha Bristol Myers Squibb: Out Of The Rut  Seeking Alpha U.S. Businesses Sour on Saudi Arabia in Blow to Crown Prince?s Growth Plans  The Wall Street Journal Bristol-Myers Squibb Company (BMY) Company Profile, News, Rankings | Fortune  Fortune Analyst Expects Bristol to Settle Over $6 Billion Bet That Didn't Pay Out  Barron's FDA OKs Bristol Myers' Orencia in Acute Graft-Vs-Host Disease >BMY  MarketWatch Bristol-Myers Squibb (BMY) Files Mixed Shelf Registration Statement  StreetInsider.com Bristol Myers is sued for refusing COVID-19 vaccine religious exemptions  Reuters It had to happen: Ex-Celgene shareholders sue Bristol Myers Squibb for $6.4B in lost CVR cash, claiming 'blatant misconduct'  FiercePharma Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis  Business Wire BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers  Yahoo Finance Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb  Yahoo Finance Bristol-Myers Squibb: Undervalued Dividend Contender, Offering Income, Dividend Growth, And Capital Appreciation  Seeking Alpha New Bristol Myers immunotherapy combo better than Opdivo alone in melanoma study  Reuters Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term  Yahoo Finance Triple Threat  Seeking Alpha Bristol Myers 24 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits against Bristol-Myers Squibb Company - BMY  Yahoo Finance Bristol Myers Gains Covid Antibody in Deal With Rockefeller  Bloomberg 3 Reasons Warren Buffett Loves Bristol-Myers Squibb  Seeking Alpha Lexicon (LXRX) Submits NDA to the FDA for Cardiovascular Drug  Yahoo Finance Bristol Myers Squibb Launches Could It Be HCM? Campaign to Increase Awareness of Hypertrophic Cardiomyopathy (HCM), the Most Common Inherited Heart Disease  Yahoo Finance Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb  Business Wire Bristol Myers 48 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits against Bristol-Myers Squibb Company - BMY  InvestingNews.com Pre-Market Most Active for Jan 10, 2022 : ZNGA, SQQQ, TLRY, QQQ, RIO, TQQQ, F, AAPL, PLTR, PHG, BMY, NIO  Nasdaq Bristol-Myers Squibb Contingent Value Rights: Thinking Through The Options Around Litigation Financing  Seeking Alpha The Executive VP & Chief Information Officer of Bristol-Myers Squibb Company (NYSE:BMY), Paul von Autenried, Just Sold 45% Of Their Holding  Simply Wall St European Shares Rebound Ahead Of Powell Comments  Nasdaq Aurinia Pharmaceuticals reverses decline after report on potential M&A interest  Seeking Alpha Bristol Myers posts $10 billion loss as it books charges relating to MyoKardia and Celgene  MarketWatch Gritstone begins phase 2/3 colorectal cancer trial dosing; positive data in early study  Seeking Alpha 3 Reasons Why Bristol Myers (BMY) Is a Great Growth Stock  Yahoo Finance ABBV: AbbVie vs. Bristol Myers Squibb: Which Pharmaceutical Stock is a Better Buy?  StockNews.com Is Bristol Myers Stock A Buy Or A Sell As Its Recent Downtrend Continues?  Investor's Business Daily Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges  FiercePharma
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources